Delivery Order SPE2DB22D6029-SPE2DB24FU0CJ
Award Date 2/26/24
Potential Completion Date 3/18/24
Potential Value $8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $11,991.63 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract provides for the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through April 15, 2024. This delivery order is part of a broader indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,242.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROMACTA 50 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,997.21 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564287146 - PROMACTA 25 MG TABLET UU 30S. This contract has a firm fixed price, with an ultimate completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025....
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,991.60 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the procurement of PROMACTA 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROMACTA 25 MG TABLET UU 30S. The $11,991.63 order is part of a $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 25 MG TABLET (30S). The contract has a ceiling value of $8,836.12 and a performance period ending on August 1, 2025. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a for-profit organization registered in SAM.gov, holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROMACTA 50 MG TABLET UU 30S. The $11,241.76 delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide the medication PROMACTA 50 MG TABLET UU 30S. The order has a potential value of $7,242.58 and a completion date of February 26, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division worth $7,242.58 for the supply of PROMACTA 50 MG TABLET UU 30S. This contract has a firm fixed price and an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves...
- This is a $23,983.26 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of PROMACTA 25 MG TABLET, a specialty medication, with a period of performance through August 2024. The contract is a firm fixed-price arrangement and does not have a small business set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0CJDelivery Order
The Defense Logistics Agency (DLA) has awarded a $7,994.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, for the provision of PROMACTA 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 6/2/24, 12:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 2/26/24 |